Jiao Zhang
Nanjing, 211100, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Reprogramming bacterial energetics reverses lactate-mediated immunosuppression for synergistic cancer immunotherapy.
Journal: Trends in biotechnology
Published: February 03, 2026
Deep learning for automated instance segmentation of residual roots in panoramic radiographs using mask R-CNN: A retrospective diagnostic accuracy study.
Journal: Medicine
Published: January 31, 2026
Intraperitoneal and intravenous paclitaxel plus S-1 and sintilimab as first-line treatment for gastric cancer with peritoneal metastasis: a single-arm phase 2 trial (DRAGON-09).
Journal: EClinicalMedicine
Published: August 13, 2025
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 04, 2024
AYVM to AYMM Transition on HER2 Exon 20 Insertion Induces Tyrosine Kinase Inhibitor Resistance in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 31, 2024
Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Journal: Medicine
Published: March 22, 2024
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study.
Journal: Nature communications
Published: March 09, 2024
Genomic correlates of the response to first-line PD-1 blockade plus chemotherapy in patients with advanced non-small-cell lung cancer.
Journal: Chinese medical journal
Published: September 30, 2023
Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.
Journal: International immunopharmacology
Published: September 20, 2023
The relationships between biological novel biomarkers Lp-PLA2 and CTRP-3 and CVD in patients with type 2 diabetes mellitus.
Journal: Journal of diabetes
Published: August 18, 2023
Value of proteinuria in evaluating the severity of HELLP and its maternal and neonatal outcomes.
Journal: BMC pregnancy and childbirth
Published: January 17, 2023
Molecular correlation of response to pyrotinib in advanced NSCLC with HER2 mutation: biomarker analysis from two phase II trials.
Journal: Experimental hematology & oncology
Published: October 26, 2022
Last Updated: 09/26/2026